Click to view graph
Connections
Click to view timeline
Timeline
Projects
Publications
Download-
2024A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
-
2024Production and evaluation of a new set of recombinant antigens for the serological diagnosis of human cysticercosis., Exp Parasitol 2024 ; 263-264(): 108803.
-
2023Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings, Diagn Microbiol Infect Dis . 2023 Apr;105(4):115903. .
-
2022Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteins., EMBO Rep 2022 May; (): e53600.
-
2021SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction., Nucleic Acids Res 2021 Jul; 49(13): 7695-7712.
-
2021Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance., Nat Commun 2021 05; 12(1): 3025.
-
2021High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris., Eur J Immunol 2021 01; 51(1): 180-190.
-
2020A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, 2020, 12 (559), pp.eabc3103. ⟨10.1126/scitranslmed.abc3103⟩.
-
2020A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus., Mol Ther 2020 08; 28(8): 1772-1782.
-
2020Human Exposure to Hantaviruses Associated with Rodents of the Murinae Subfamily, Madagascar, Emerging Infect. Dis. 2020 Mar;26(3):587-590.
-
+View full list of publications